You have searched for "Samsung Biologics"
Showing 1-10 of 39
NEW YORK: Wall Street closed lower on Thursday, retreating late in thin holiday volume from record highs set early in the session on strong U.S. data including a drop in weekly claims for U.S. unemployment benefits.
SEOUL (Reuters) - Samsung Electronics vice chairman Jay Y. Lee is visiting North America in his first high-profile trip after serving jail time for bribery, with a decision imminent on the company's planned $17 billion U.S. chip plant.
News highlights from Asean countries in the Star-AseanPlus section for Tuesday (Oct 26)
SEOUL (Reuters): South Korea granted emergency use approval for Moderna's Covid-19 vaccine produced by South Korean drugmaker Samsung BioLogics, the health ministry said on Tuesday (Oct 26).
SEOUL (The Korea Herald/ANN): Samsung Group’s de facto chief Lee Jae-yong is going full speed ahead after returning to the office on Aug 17, tending to tasks waiting for his attention at Samsung Electronics.
SEOUL (Reuters): South Korean President Moon Jae-in said on Thursday (Aug 5) he plans to invest 2.2 trillion won (US$1.92 billion) to turn the country into one of the world's five largest Covid-19 vaccine manufacturing bases by 2025, his office said.
SEOUL (Reuters) -South Korean President Moon Jae-in said on Thursday he plans to invest 2.2 trillion won ($1.92 billion) to turn the country into one of the world's five largest COVID-19 vaccine manufacturing bases by 2025, his office said.
Exclusive: South Korea in talks with mRNA vaccine makers to make up to 1 billion doses -government official
SEOUL (Reuters) - South Korea is in talks with mRNA vaccine makers including Pfizer and Moderna to produce COVID-19 shots in the country and is ready to offer the capacity to make up to 1 billion doses immediately, a senior government official said.
SEOUL (Reuters) - South Korea on Friday approved Moderna Inc's COVID-19 vaccine, as the country attempts to speed up its inoculation efforts, drug safety minister Kim Gang-lip told a news conference.
SEOUL (Reuters) - South Korea's struggle to boost coronavirus vaccine supplies is threatening to overshadow President Moon Jae-in's first summit with U.S. President Joe Biden, with pressure mounting on Moon to secure more and faster deliveries of U.S.-made shots.